Lu Kang Pharmaceuticals and Inspur Group Strategic Cooperation Agreement Signing and Procurement Supply Chain Platform Construction Project Officially Launched

robot
Abstract generation in progress

(Source: Lu Kang Pharmaceutical)

On March 19, Lu Kang Pharmaceutical and Inspur Group held a signing ceremony for strategic cooperation and the launch of the procurement and supply chain platform construction project at Lu Kang Pharmaceutical’s formulation park. This event marks the official establishment of a comprehensive strategic partnership between the two parties, jointly embarking on a new journey of digital transformation across all fields of Lu Kang Pharmaceutical. The collaboration aims to enable the company to achieve intelligent upgrades in research and development, production, operations, and management, supporting high-quality development. Peng Xin, Party Secretary and Chairman of Lu Kang Pharmaceutical, and Wei Daisen, Vice President of Inspur Group and Chairman of Inspur Digital Enterprise, attended the signing ceremony and launch event. Lu Kang Pharmaceutical’s Deputy General Manager Cao Haifeng and Inspur Digital Enterprise’s Deputy General Manager Kong Bing signed the strategic cooperation agreement on behalf of both sides.

Peng Xin emphasized that digital transformation has become an essential path for state-owned enterprises to achieve high-quality development. As the core hub of enterprise operations, the efficiency and management quality of procurement and supply chain directly determine the company’s market competitiveness and sustainable growth. Lu Kang Pharmaceutical attaches great importance to digital and intelligent transformation, continuously promoting informatization, automation, and intelligent upgrades of traditional industries. The company has been awarded the Ministry of Industry and Information Technology’s Excellent Smart Factory, the Ministry’s Industrial Internet Pilot Demonstration Project, Shandong Province’s Advanced Smart Factory, and the first batch of digital economy innovation platforms in Shandong Province.

Chairman Peng Xin highlighted that Inspur Group, as a leading domestic provider of cloud computing and big data services, is a world-class leader in new-generation information technology, possessing full-stack digital capabilities and extensive industry experience. The two parties will take this signing as a new starting point, adhering to the principles of integrity, win-win cooperation, and efficient collaboration. They will focus on building the procurement and supply chain platform, advancing digital transformation in areas such as computer equipment, basic software, and AI artificial intelligence, and jointly creating a benchmark model for digital transformation in the pharmaceutical industry.

Wei Daisen, Vice President of Inspur Group and Chairman of Inspur Digital Enterprise, congratulated the successful signing of the strategic cooperation. He stated that Inspur Group, as a leading domestic new-generation information technology enterprise, has deep technical expertise and a mature service system in core areas such as cloud computing, big data, industrial internet, and artificial intelligence. Inspur values its strategic partnership with Lu Kang Pharmaceutical highly and will leverage its technological and service advantages to focus on the core needs of digital construction. The company will fully support Lu Kang Pharmaceutical’s digital transformation by providing strong technical support and high-quality services in procurement and supply chain management, financial intelligence, AI scenario implementation, and smart manufacturing upgrades, promoting mutual benefits and win-win cooperation.

The signing of this strategic cooperation and the launch of the procurement and supply chain platform construction project represent an important milestone in Lu Kang Pharmaceutical’s implementation of its digital development strategy and its pursuit of high-quality growth. The company will leverage this project as an opportunity to accelerate the digital and intelligent upgrades across research, production, operations, and management, optimize business processes, enhance core competitiveness, and continuously promote high-quality development.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin